Table 3 Summary of safety for all treated patients
Adverse events, n (%) | Atezo n = 234 | Chemo n = 221 |
|---|---|---|
All-grade adverse events due to any cause | 216 (92) | 216 (98) |
Treatment-related adverse events | 138 (59) | 194 (88) |
Grade 3/4 adverse events | 107 (46) | 127 (58) |
Treatment-related grade 3/4 adverse events | 43 (18) | 102 (46) |
Serious adverse events | 104 (44) | 82 (37) |
Treatment-related serious adverse events | 27 (12) | 32 (14) |
Grade 5 adverse events | 13 (6) | 12 (5) |
Treatment-related grade 5 adverse events | 0 | 3 (1) |
Adverse events leading to any treatment withdrawal | 23 (10) | 44 (20) |
Adverse events of special interest | ||
All-grade adverse events of special interest | 95 (42) | 58 (26) |
Grade 3/4 adverse events of special interest | 29 (12) | 10 (5) |
All-grade adverse events of special interest requiring use of corticosteroids | 41 (18) | 20 (9) |
